Previous 10 | Next 10 |
Gainers: Alterity Therapeutics (ATHE) +103%, TRxADE HEALTH (MEDS) +62%, Pulse Biosciences (PLSE) +22%, Spero Therapeutics (SPRO) +12%, Kintara Therapeutics (KTRA) +6%.Losers: Citius Pharmaceuticals (CTXR) -21%, Aligos Therapeutics (A...
Alterity Therapeutics Limited (ATHE) +57% on a new patent by USPTO.Birks Group (BGI) +49% on re-opening of its retail stores across Canada.Wunong Net Technology Company (WNW) +46%.Spero Therapeutics (SPRO) +23% on $40M equity investment from Pfizer.Bridgeline Digital (BLIN) +21...
Alterity Therapeutics granted a new US patent targeting major neurodegenerative diseases including Alzheimer's and Parkinson's PR Newswire MELBOURNE, Australia and SAN FRANCISCO , July 1, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE)...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, investor! We’re starting the day off with a deep dive into the biggest pre-market stock movers for Thursday! Source: f11photo/Shutterstock.com But before that, let’s stop a look at what t...
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial PR Newswire Highlights: Alterity receives positive guidance from the European Medicines Agency's Committee for Medicinal Products for Human Use on its Ph...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Good morning, traders! We’re starting off the day with a look at the biggest pre-market stock market movers for Wednesday. That includes those that are seeing the largest gains and losses in early morning trading. ...
Alterity Therapeutics Limited Appendix 4C - Q3 FY21 Quarterly Cash Flow Report PR Newswire Highlights: Michael J. Fox Foundation grants Alterity $US495K for Parkinson's disease research evaluation Strengthening profile at investment, scientific and clin...
Alterity Therapeutics (ATHE) +22%.Welbilt (WBT) +19% on being acquired by The Middleby Corp.Sierra Metals (SMTS) +12%.Williams Industrial Services (WLMS) +12%.Uxin Limited (UXIN) +9%.inTEST Corporation (INTT) +8%.Ocugen (OCGN) +7%.Energy Recover (ERII) +7%.Cerecor (CERC) +6%.Aesthetic Me...
ATH434 protects brain cells and improves motor function in Parkinsonian disorder Oral presentation at the American Academy of Neurology PR Newswire MELBOURNE, Australia , April 21, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Alright, investors! We’ve reached the midpoint of the week but there’s no time to start slacking off just yet! Instead, get ready to look over the biggest pre-market movers for Wednesday as we prepare for anot...
News, Short Squeeze, Breakout and More Instantly...
Alterity Therapeutics Limited Company Name:
ATHE Stock Symbol:
NYSE Market:
Alterity Therapeutics Limited Website:
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers Demonstrated Improvement Consistent with Clinical Findings ...
– 43% of Participants Showed Improvement on the UMSARS Activities of Daily Living Scale – – 29% of Participants had Stable or Improved Neurological Symptoms – – Objective Biomarkers Demonstrated Improvement Consistent with Clinical Findings ...
MELBOURNE, Australia and SAN FRANCISCO, June 12, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today an...